Moderna Says Norovirus Vaccine Didn’t Meet Statistical Criteria for Early Success in Trial

Date:




Moderna narrowed its loss in the recent quarter as revenue climbed, boosted by deliveries made under a government contract in the U.K.



Source link

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

Every NFL team’s best training camp, preseason riser ever

NFL NationJul 31, 2026, 06:00 AM ETCloseNFL Nation is...

Oprah Winfrey says she will close her school for girls in South Africa next year

Oprah Winfrey says she will close her school for...

AbbVie Lowers Outlook to Account for Acquisition as Profit Jumps

AbbVie lowered its full-year adjusted earnings outlook to account...